2 reports

EDIT COMPLETED HER PHD IN CANCER IMMUNOLOGY/ IMMUNOTHERAPY AT ST.

  • Immunotherapy
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • Alcon, Inc.

VAXIMM will be responsible for conducting two open-label Phase I/ II trials - one in glioblastoma and one in metastatic colorectal cancer.

  • Immunotherapy
  • Therapy
  • Alcon, Inc.
  • Genentech, Inc.
  • Roche Group